FDA National Drug Codes
Searching…
FDA National Drug Codes
Searching…
FDA National Drug Codes
Browse every product in the FDA NDC Directory below, or search by NDC, brand, generic, manufacturer or HCPCS code. Each product has its own page with package NDCs in 11-digit billing format.
381 products (finished products)
| Product | Strength | Form · route | Labeler | Application | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|---|
| Xenletalefamulin acetate | Lefamulin acetate 150 mg/15mL | Injection, SolutionIntravenous | Meitheal Pharmaceuticals Inc. | NDA | 71288-039 | 71288-0039-16 | — |
| Xenonxenon xe-133 | Xenon xe-133 10 mCi/1 | GasRespiratory (Inhalation) | Lantheus Medical Imaging, Inc. | NDA | 11994-127 | 11994-0127-1111994-0127-15 | — |
| Xenonxenon xe-133 | Xenon xe-133 20 mCi/1 | GasRespiratory (Inhalation) | Lantheus Medical Imaging, Inc. | NDA | 11994-128 | 11994-0128-2111994-0128-25 | — |
| Xenonxenon xe-133 |
| Xenon xe-133 10 mCi/1 |
| GasRespiratory (Inhalation) |
| Shine Spect USA, LLC |
| NDA |
| 87333-127 |
| 87333-0127-1187333-0127-15 |
| — |
| Xenonxenon xe-133 | Xenon xe-133 20 mCi/1 | GasRespiratory (Inhalation) | Shine Spect USA, LLC | NDA | 87333-128 | 87333-0128-2187333-0128-25 | — |
|---|
| Xenon, Xe-133xenon | Xenon xe-133 5 mCi/mL | GasRespiratory (Inhalation) | Curium US LLC | NDA | 69945-097 | 69945-0097-1169945-0097-1369945-0097-15 | — |
|---|
| Xenon, Xe-133xenon | Xenon xe-133 10 mCi/mL | GasRespiratory (Inhalation) | Curium US LLC | NDA | 69945-098 | 69945-0098-2169945-0098-2369945-0098-25 | — |
|---|
| Xenoviewxenon xe 129 hyperpolarized | Xenon xe-129, Hyperpolarized 75 mL/300mL | GasRespiratory (Inhalation) | Polarean, Inc. | NDA | 80534-0300 | 80534-0300-01 | — |
|---|
| Xenoviewxenon xe 129 hyperpolarized | Xenon xe-129, Hyperpolarized 75 mL/500mL | GasRespiratory (Inhalation) | Polarean, Inc. | NDA | 80534-0500 | 80534-0500-01 | — |
|---|
| Xenoviewxenon xe 129 hyperpolarized | Xenon xe-129, Hyperpolarized 75 mL/750mL | GasRespiratory (Inhalation) | Polarean, Inc. | NDA | 80534-0750 | 80534-0750-01 | — |
|---|
| Xenoviewxenon xe 129 hyperpolarized | Xenon xe-129, Hyperpolarized 75 mL/L | GasRespiratory (Inhalation) | Polarean, Inc. | NDA | 80534-1000 | 80534-1000-0180534-1000-02 | — |
|---|
| Xenoviewxenon xe 129 hyperpolarized | Xenon xe-129 63.5 L/1 + 2 more ingredients | GasRespiratory (Inhalation) | Polarean, Inc. | NDA | 80534-6350 | 80534-6350-01 | — |
|---|
| Xenpozymeolipudase alfa-rpcp | Olipudase alfa 20 mg/5.1mL | Injection, Powder, Lyophilized, For solutionIntravenous | Genzyme Corporation | BLA | 58468-0050 | 58468-0050-01 | — |
|---|
| Xenpozymeolipudase alfa-rpcp | Olipudase alfa 4 mg/1.1mL | Injection, Powder, Lyophilized, For solutionIntravenous | Genzyme Corporation | BLA | 58468-0051 | 58468-0051-01 | — |
|---|
| Xeominincobotulinumtoxina | Botulinum toxin type a 50 [USP'U]/1 | Injection, Powder, Lyophilized, For solutionIntramuscular | Merz Pharmaceuticals, LLC | BLA | 0259-1605 | 00259-1605-01 | — |
|---|
| Xeominincobotulinumtoxina | Botulinum toxin type a 100 [USP'U]/1 | Injection, Powder, Lyophilized, For solutionIntramuscular | Merz Pharmaceuticals, LLC | BLA | 0259-1610 | 00259-1610-01 | — |
|---|
| Xeominincobotulinumtoxina | Botulinum toxin type a 200 [USP'U]/1 | Injection, Powder, Lyophilized, For solutionIntramuscular | Merz Pharmaceuticals, LLC | BLA | 0259-1620 | 00259-1620-0100259-1620-10 | — |
|---|
| Xeominincobotulinumtoxina | Botulinum toxin type a 100 [USP'U]/1 | Injection, Powder, Lyophilized, For solutionIntramuscular | Merz Pharmaceuticals, LLC | BLA | 0259-4110 | 00259-4110-01 | — |
|---|
| Xeominincobotulinumtoxina | Botulinum toxin type a 50 [USP'U]/1 | Injection, Powder, Lyophilized, For solutionIntramuscular | Merz Pharmaceuticals, LLC | BLA | 0259-4150 | 00259-4150-01 | — |
|---|
| Xeominincobotulinumtoxina | Botulinum toxin type a 100 [USP'U]/1 | Injection, Powder, Lyophilized, For solutionIntramuscular | Merz North America, Inc. | BLA | 46783-160 | 46783-0160-0146783-0160-10 | — |
|---|
| Xeominincobotulinumtoxina | Botulinum toxin type a 50 [USP'U]/1 | Injection, Powder, Lyophilized, For solutionIntramuscular | Merz North America, Inc. | BLA | 46783-161 | 46783-0161-01 | — |
|---|
| Xeominincobotulinumtoxina | Botulinum toxin type a 50 [USP'U]/1 | Injection, Powder, Lyophilized, For solutionIntramuscular | Merz North America, Inc. | BLA | 46783-165 | 46783-0165-01 | — |
|---|
| Xerac AC | Aluminum chloride .0625 g/g | LiquidTopical | Person and Covey | OTC monograph drug | 0096-0709 | 00096-0709-3500096-0709-60 | — |
|---|
| Xeravaeravacycline | Eravacycline dihydrochloride 50 mg/1 | Injection, Powder, Lyophilized, For solutionIntravenous | Tetraphase Pharmaceuticals, Inc. | NDA | 71773-050 | 71773-0050-0571773-0050-12 | — |
|---|
| Xeravaeravacycline | Eravacycline dihydrochloride 100 mg/1 | Injection, Powder, Lyophilized, For solutionIntravenous | Tetraphase Pharmaceuticals, Inc. | NDA | 71773-100 | 71773-0100-12 | — |
|---|
| Xereseacyclovir and hydrocortisone | Acyclovir 50 mg/g; Hydrocortisone 10 mg/g | CreamTopical | Bausch Health US LLC | NDA | 0187-5104 | 00187-5104-01 | — |
|---|
| Xermelotelotristat ethyl | Telotristat ethyl 250 mg/1 | TabletOral | Lexicon Pharmaceuticals, Inc. | NDA | 70183-125 | — | — |
|---|
| Xermelotelotristat ethyl | Telotristat ethyl 250 mg/1 | TabletOral | TerSera Therapeutics LLC | NDA | 70720-125 | 70720-0125-85 | — |
|---|
| XeroBurn Burn Gellidocaine hydrochloride | Lidocaine hydrochloride 2 g/100g | GelTopical | Dynarex Corporation | OTC monograph drug | 67777-129 | 67777-0129-0267777-0129-0967777-0129-10+1 more | — |
|---|
| Xerophyllum Asphodeloides | Xerophyllum asphodeloides 6 [hp_C]/1 | PelletOral | Hahnemann Laboratories, INC. | Unapproved homeopathic | 37662-2397 | 37662-2397-0137662-2397-0237662-2397-03 | — |
|---|
| Xerophyllum Asphodeloides | Xerophyllum asphodeloides 12 [hp_C]/1 | PelletOral | Hahnemann Laboratories, INC. | Unapproved homeopathic | 37662-2398 | 37662-2398-0137662-2398-0237662-2398-03 | — |
|---|
| Xerophyllum Asphodeloides | Xerophyllum asphodeloides 30 [hp_C]/1 | PelletOral | Hahnemann Laboratories, INC. | Unapproved homeopathic | 37662-2399 | 37662-2399-0137662-2399-0237662-2399-03+1 more | — |
|---|
| Xerophyllum Asphodeloides | Xerophyllum asphodeloides 100 [hp_C]/1 | PelletOral | Hahnemann Laboratories, INC. | Unapproved homeopathic | 37662-2400 | 37662-2400-0137662-2400-0237662-2400-03+1 more | — |
|---|
| Xerophyllum Asphodeloides | Xerophyllum asphodeloides 200 [hp_C]/1 | PelletOral | Hahnemann Laboratories, INC. | Unapproved homeopathic | 37662-2401 | 37662-2401-0137662-2401-0237662-2401-03+1 more | — |
|---|
| Xerophyllum Asphodeloides | Xerophyllum asphodeloides 500 [hp_C]/1 | PelletOral | Hahnemann Laboratories, INC. | Unapproved homeopathic | 37662-2402 | 37662-2402-0137662-2402-0237662-2402-03+1 more | — |
|---|
| Xerophyllum Asphodeloides | Xerophyllum asphodeloides 1 [hp_M]/1 | PelletOral | Hahnemann Laboratories, INC. | Unapproved homeopathic | 37662-2403 | 37662-2403-0137662-2403-0237662-2403-03+1 more | — |
|---|
| Xesso Neobenzocaine | Benzocaine 5 g/100mL | SprayOral, Topical | PREMIUM NATURAL COSMETICS INC | OTC monograph drug | 81777-106 | 81777-0106-04 | — |
|---|
| Xesso Rear Comfort Glidelidocaine | Lidocaine hydrochloride 2.35 g/100mL | GelRectal | PREMIUM NATURAL COSMETICS INC | OTC monograph drug | 81777-104 | 81777-0104-01 | — |
|---|
| Xesso Strawberry Rear Comfort Glide 4% Lidocainelidocaine | Lidocaine hydrochloride 4.625 g/100mL | GelRectal | Premium Natural Cosmetics Inc | OTC monograph drug | 81777-105 | 81777-0105-01 | — |
|---|
| Xexlvov Milia Removersalicylic acid 1% milia remover liquid | Salicylic acid 1 g/100mL | LiquidTopical | Shanghai Honghui Chuang Intelligent Technology Co., Ltd | OTC monograph drug | 87312-147 | 87312-0147-01 | — |
|---|
| Xgevadenosumab | Denosumab 120 mg/1.7mL | InjectionSubcutaneous | Amgen, Inc | BLA | 55513-730 | 55513-0730-0155513-0730-21 | J0897 |
|---|
| Xhancefluticasone propionate | Fluticasone propionate 93 ug/1 | Spray, MeteredNasal | OptiNose US, Inc. | NDA | 71143-375 | 71143-0375-0171143-0375-98 | — |
|---|
| Xhancefluticasone propionate | Fluticasone propionate 93 ug/1 | Spray, MeteredNasal | Paratek Pharmaceuticals, Inc. | NDA | 71715-003 | 71715-0003-3171715-0003-3271715-0003-33 | — |
|---|
| Xhc-075alcohol | Alcohol 68.4 mL/100mL | SolutionTopical | Ecolab Inc. | OTC monograph drug | 47593-658 | 47593-0658-4147593-0658-70 | — |
|---|
| Xhc-79ethyl alcohol | Alcohol 68.4 mL/100mL | SolutionTopical | Ecolab Inc. | OTC monograph drug | 47593-656 | 47593-0656-70 | — |
|---|
| Xiaflexcollagenase clostridium histolyticum | — | Kit | Endo USA, Inc. | BLA | 66887-003 | 66887-0003-0166887-0003-02 | — |
|---|
| Xiclodiclofenac | Diclofenac .0125 g/g | PatchTransdermal | Asclemed USA, Inc. | Unapproved drug (other) | 76420-332 | 76420-0332-10 | — |
|---|
| Xiclodiclofenac | Diclofenac .0125 g/g | PatchTransdermal | Strand Health Group | Unapproved drug (other) | 83295-5500 | 83295-5500-01 | — |
|---|
| Xiclofendiclofenac sodium, methyl salicylate | Diclofenac sodium .01 g/g; Methyl salicylate .05 g/g | OintmentCutaneous | STRAND HEALTH GROUP | Unapproved drug (other) | 83295-5050 | 83295-5050-01 | — |
|---|
| Xiclofendiclofenac sodium, methyl salicylate | Diclofenac sodium .01 g/g; Methyl salicylate .05 g/g | OintmentCutaneous | ASCLEMED USA INC. | Unapproved drug (other) | 87063-056 | 87063-0056-85 | — |
|---|